DrugDev Sponsors 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November 2014

Share Article

DrugDev is sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November. Five investigators and site staff who are members of the DrugDev Network will serve as key thought leaders in interactive and educational panels during the conference.

DrugDev provides technology-driven solutions that help investigators, sponsors and CROs do more clinical trials together.

DrugDev is proud to be sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November.

Five investigators and site staff who are members of the DrugDev Network will serve as key thought leaders in interactive and educational panels during the conference:

  • Overcoming Challenges in the Day-to-Day Operation of Patient Recruitment
  • Real-Life Examples of the Best Methods for Site Feasibility
  • Investigator Engagement: What Should the Sponsor and CRO Do to Optimise Engagement?

DrugDev’s mission is to make the lives of clinical trial investigators easier. Part of that mission is to ensure investigators and site voices are part of key conversations in the drive to improve the conduct and efficiency of clinical trials.

DrugDev provides technology-driven solutions that help investigators, sponsors and CROs do more clinical trials together. Learn more at http://www.drugdev.com.

About DrugDev
DrugDev simplifies life at the clinical trial site through technology and enables sponsors, CROs and investigators to do more trials together. DrugDev creates and drives standards which promote collaboration, improve quality, shorten timelines and reduce cost. Our solutions include the largest global network of active investigators; the industry’s leading grant payment and site contracting system in CFS Clinical; and, the award-winning TrialNetworks platform of clinical operations apps. DrugDev provides Hosted Data Solutions for clinical trials including hosting the Investigator Databank for Novartis, Janssen, Merck, Lilly and Pfizer. Learn more at drugdev.com.

Media Contact:
Brenda Nashawaty
+1 617.688.3253
brenda(at)nashawaty(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Nashawaty
DrugDev
+1 617-688-3253
Email >

Kristopher Sarajian
DrugDev
617-952-4071 132
Email >
Visit website

Media